Latest News

G Mining Ventures (TSX:GMIN) is back on investor radars after reporting a 221% year over year increase in mineral reserves, driven mainly by the Oko West Feasibility Study and broader portfolio progress. See our latest analysis for G Mining Ventures. The Feasibility Study news and reserve update arrive after a sharp pullback, with a 24.17% 7 day share price return decline and a 6.91% one day drop, yet the 1 year total shareholder return of 109.88% and very large 5 year total shareholder...

Akso Health Group (AHG) recently hit a new 52 week high at US$2.10, alongside reported 75.6% revenue growth and a 30% total return over the past year, despite a thin 1% gross margin. See our latest analysis for Akso Health Group. The latest move to US$2.42 comes after a strong run, with an 84.7% 1 month share price return and a 51.3% year to date share price return. The 1 year total shareholder return of 92.1% and very large 3 year total shareholder return suggest momentum has been building...

Resolute Holdings Management (RHLD) has drawn fresh attention after recent trading left the stock with a 9% decline over the past month and a 24% decline over the past three months, sharpening focus on its valuation profile. See our latest analysis for Resolute Holdings Management. Despite the recent 30 day and 90 day share price returns of 8.6% and 24.6% declines, respectively, the 1 year total shareholder return of about 3.7x and the latest $164.17 share price point to fading short term...

Accelerant Holdings (ARX) closed FY 2025 with fourth quarter revenue of US$326.9 million and a basic EPS loss of US$0.0027, while the trailing twelve month figures showed revenue of US$912.9 million and a basic EPS loss of US$7.49. Over recent periods, the company has seen quarterly revenue move from US$181.2 million in Q4 2024 to US$163.5 million in Q1 2025, US$204.7 million in Q2 2025, US$217.8 million in Q3 2025 and US$326.9 million in Q4 2025, with EPS shifting from US$10.57 in Q4 2024 to...

US FDA has approved Wegovy HD, a 7.2 mg higher dose of semaglutide, for obesity and long term weight management. The decision followed an expedited review supported by a priority review voucher, highlighting regulatory focus on obesity treatments. Novo Nordisk, ticker CPSE:NOVO B, is preparing for an imminent US commercial launch of Wegovy HD. For investors watching CPSE:NOVO B, the Wegovy HD approval arrives after a challenging share price period. The stock trades at DKK237.9, with returns...

Sun Life Financial: Recent Returns Put Valuation in Focus Sun Life Financial (TSX:SLF) has drawn attention after a recent one-month return of about a 7% decline, contrasting with a modest gain over the past three months and a positive one-year total return. See our latest analysis for Sun Life Financial. The share price has softened recently, with a 30 day share price return of about a 7% decline and the latest close at CA$85.95. The 1 year total shareholder return of roughly 10.5% points to...

Healwell AI (TSX:AIDX) has just wrapped up FY 2025 with Q4 revenue of $32.2 million and a basic EPS loss of $0.02, alongside trailing 12 month revenue of $103.8 million and a basic EPS loss of $0.16. The company has seen quarterly revenue move from $15.2 million in Q4 2024 to $32.2 million in Q4 2025. Basic EPS over the same quarters shifted from a loss of $0.25 to a loss of $0.02, setting up a picture where top line scale is building but margins are still under pressure for shareholders...

Lucid Group (LCID) continues to draw attention from EV investors, with shares most recently closing at US$10.30. Recent returns include a single-day gain of 3.5% and a decline of 12.9% over the past three months. See our latest analysis for Lucid Group. The recent 3.5% one day share price return and 4.7% 7 day share price return contrast with a 12.9% 90 day share price decline and a 54.8% 1 year total shareholder return loss. This suggests momentum has been weak over the longer term. If...

FDA approval sets new context for Protagonist Therapeutics The recent U.S. FDA approval of ICOTYDE for moderate to severe plaque psoriasis is a major regulatory milestone for Protagonist Therapeutics (PTGX). This development is putting fresh attention on the company’s commercial potential and broader pipeline. See our latest analysis for Protagonist Therapeutics. The FDA approval has arrived after a strong run in the shares, with a 23.31% 1 month share price return and a 91.67% 1 year total...

Lands' End (LE) has rounded out FY 2026 with Q4 revenue of US$462.4 million and basic EPS of US$0.40, supported by net income of US$12.3 million. Over recent quarters, the company has seen revenue move from US$261.2 million in Q1 2026 to US$317.5 million in Q3 2026 before reaching US$462.4 million in Q4. Quarterly EPS shifted from a loss of US$0.27 in Q1 to a profit of US$0.40 in Q4. For investors, the focus now is on how sustainable these earnings are given the thin trailing net profit...

Semperit Holding (WBAG:SEM) FY 2025 earnings snapshot Semperit Holding (WBAG:SEM) closed FY 2025 with fourth quarter revenue of €179.8 million and basic EPS of €0.40, alongside net income of €8.9 million. These figures help frame how investors assess the year just finished. The company reported quarterly revenue of €170.4 million and EPS of €0.21 in Q4 2024, compared with €179.8 million and €0.40 in Q4 2025. Trailing twelve month EPS stands at €0.02 on revenue of €665.1 million, keeping...

Wondering if Jack Henry & Associates is priced attractively or already fully valued at around US$164 a share? This article breaks down what that current price might imply about the stock. The share price has moved by a 1.1% decline over the last week, a 3.7% gain over the last 30 days, and a 7.8% decline year to date, with a 4.9% decline over the last year and returns of 16.7% over three years and 14.6% over five years. That mix of shorter term weakness and longer term gains provides context...

If you are wondering whether Steel Dynamics at around US$167.56 is offering fair value or not, the key is to separate short term noise from the longer term valuation picture. The share price has seen a 4.3% decline over the last 7 days and a 12.7% decline over the last 30 days, even though the 1 year return sits at 34.2% and the 5 year return is 281.7%. Recent news coverage has focused on Steel Dynamics as a major US steel producer, with attention on how its capital allocation, capacity...

Curious whether Vertiv Holdings Co at around US$269 per share is still offering value after such a strong run, or if you are late to the story. The stock has recently posted returns of 1.4% over 7 days, 10.5% over 30 days, 53.3% year to date and 202.5% over the last year, with a very large 3 year gain and strong 5 year performance. Recent coverage has focused on Vertiv as a key player supplying critical power and cooling infrastructure for data centers and AI related workloads, which has...

If you are wondering whether Nu Holdings at US$14.16 still offers value or if most of the easy gains are already behind it, this article walks through what the current price might be implying. The stock is up 1.4% over the past week, while showing a 15.8% decline over the last month and a 16.8% decline year to date, set against a 24.2% return over the past year and a very large three-year gain of around 3x. Recent coverage of Nu Holdings has focused on its position as a fast-growing digital...

Kolibri Global Energy (TSX:KEI) has just wrapped up FY 2025 with fourth quarter revenue of US$14.7 million and basic EPS of US$0.09. This sits alongside trailing twelve month revenue of US$57.4 million and EPS of US$0.44. Over recent periods the company has seen quarterly revenue range from US$11.1 million to US$16.4 million and EPS move between roughly US$0.08 and US$0.16. Trailing net profit margin is 27% compared with 30.9% last year, creating an earnings story that depends on how...

Assessing Coty after recent share price pressure Coty (COTY) has come under pressure recently, with the share price showing negative returns over the past month, past 3 months and year. For investors, the key question is whether current levels fairly reflect its fundamentals. See our latest analysis for Coty. At a share price of US$2.15, Coty’s recent 30 day share price return of a 16.02% decline and year to date share price return of a 30.87% decline point to fading momentum and a weaker 1...

What Triggered The Latest Focus On Eos Energy Enterprises (EOSE)? A new class action lawsuit against Eos Energy Enterprises (EOSE) has sharpened attention on the stock after allegations that earlier statements about production capabilities and financial guidance did not match later disclosures. The suit follows the company’s fourth quarter and full year 2025 update, where reported revenue of US$114.2 million was below prior guidance and management outlined production inefficiencies and...

Why Hartford Insurance Group (HIG) is on investors’ radar today Hartford Insurance Group (HIG) has drawn fresh attention after recent trading left the shares with a 1 day return of about a 1% decline and a month move near an 8% decline. That short term pullback sits against a 1 year total return of about 12% and multi year total returns above 100%. This has prompted some investors to reassess what the current US$131.36 share price implies. See our latest analysis for Hartford Insurance...

Avidbank Holdings (AVBH) just posted its FY 2025 fourth quarter numbers with revenue of US$23.9 million and EPS of US$0.66, alongside net income of US$6.9 million. Over the past year, revenue has moved from US$20.3 million in Q4 FY 2024 to US$23.9 million in Q4 FY 2025, while quarterly EPS has shifted from US$0.87 to US$0.66. With forecasts pointing to faster top line expansion and a path toward improving profitability over time, the latest print gives you a fresh read on how margins are...

Wondering whether Intercontinental Exchange at around US$158.50 is starting to look attractively priced, or if the stock still has more optimism baked in than the numbers support. The share price has moved only slightly over the last week with a 0.1% decline, while the 30 day return sits at 3.3%, the year to date return is a 0.9% decline, and the 1 year return is an 8.7% decline. These figures compare with a 70.5% return over 3 years and 50.6% over 5 years. Recent coverage has focused on how...

Recent moves around XPLR Infrastructure (NYSE:XIFR) have centred on an Evercore ISI downgrade linked to its ongoing restructuring, along with new clean energy plans that include expanded repowering capacity and new battery co-investments with NextEra Energy. See our latest analysis for XPLR Infrastructure. Those restructuring headlines appear to be landing in a mixed way with investors, with a 1 day share price return of negative 1.53% and a 7 day share price return of negative 3.30%, while...

U.S. District Court certifies consumer antitrust class actions against Altria Group and Juul Labs related to the e vapor market. The lawsuit focuses on alleged anticompetitive practices tied to the sale of Juul pods. Class certification marks a key procedural step that could affect Altria Group's future legal and financial exposure. For investors following Altria Group, NYSE:MO, this legal update arrives while the stock trades at $65.07. Shares are up 13.5% year to date and 20.0% over the...

Sol-Gel Technologies (SLGL) closed FY 2025 with fourth quarter revenue of US$0.7 million and a basic EPS loss of US$1.07, alongside a net income loss of US$3.0 million. On a trailing twelve month basis the company remained unprofitable, with revenue of US$19.4 million, a net income loss of US$6.1 million, and basic EPS of US$2.20 in the red. Over recent quarters, revenue has ranged from US$0.4 million to US$17.3 million and EPS has swung between a loss of US$3.16 and a profit of US$4.17. This...